| mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
| mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.24 |
3e-05 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
| mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0001 |